Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system

The immune-privileged status of the central nervous system (CNS) has changed quite dramatically during the past two decades. Leukocytes have the ability to infiltrate the CNS and cytokines are produced by resident cells, especially during injuries and diseases. Although the cellular source and role of these immune ligands are better known, their exact contribution to brain protection, repair or diseases still remains highly debated today. The ultimate fate of the immune reaction depends on the cytokines involved and the experimental models. It is now generally accepted that microglia play a central role in this response, at least for the production of cytokines participating in the innate immune system. As macrophages, resident microglia produce numerous cytokines and two of them have been largely studied since the beginning of this field of research. Twenty years ago, interleukin 1 (IL-1) and tumor-necrosis factor (TNF) were cloned and recombinant forms were used to investigate their functions ranging from normal neurophysiological responses to pathological conditions. This review presents the history of these two cytokines during immune responses in the brain and where we are now two decades later.

[1]  Michael Karin,et al.  Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation , 1999 .

[2]  J Q Trojanowski,et al.  Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Giulian,et al.  Immunoregulation of cells within the central nervous system , 1988, Brain, Behavior, and Immunity.

[4]  J. Ting,et al.  TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.

[5]  R. Dantzer,et al.  Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior , 2002, Journal of Neuroimmunology.

[6]  K. Frei,et al.  Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .

[7]  P. Kochanek,et al.  Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain , 1996, Annals of neurology.

[8]  F. Barone,et al.  Cytokines in Brain Ischemia—The Role of TNFα , 1998, Cellular and Molecular Neurobiology.

[9]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[10]  B. Rosen,et al.  Role of matrix metalloproteinases in delayed cortical responses after stroke , 2006, Nature Medicine.

[11]  A. C. Webb,et al.  Interleukin-1 gene (IL1) assigned to long arm of human chromosome 2. , 1986, Lymphokine research.

[12]  S. Rivest,et al.  An Essential Role of Interleukin-1β in Mediating NF-κB Activity and COX-2 Transcription in Cells of the Blood–Brain Barrier in Response to a Systemic and Localized Inflammation But Not During Endotoxemia , 1999, The Journal of Neuroscience.

[13]  S. Rivest,et al.  Endotoxemia Prevents the Cerebral Inflammatory Wave Induced by Intraparenchymal Lipopolysaccharide Injection: Role of Glucocorticoids and CD141 , 2002, The Journal of Immunology.

[14]  S. Levison,et al.  Interleukin‐1: A master regulator of neuroinflammation , 2004, Journal of neuroscience research.

[15]  S. Rivest,et al.  Tumor Necrosis Factor α But Not Interleukin 1β Mediates Neuroprotection in Response to Acute Nitric Oxide Excitotoxicity , 2006, The Journal of Neuroscience.

[16]  D. Giulian Ameboid microglia as effectors of inflammation in the central nervous system , 1987, Journal of neuroscience research.

[17]  S. Rivest,et al.  Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response , 2003, The Journal of Neuroscience.

[18]  M. Satoh,et al.  Induction of Interleukin‐1β mRNA in Rat Brain After Transient Forebrain Ischemia , 1992 .

[19]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[20]  L. Benowitz,et al.  Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells , 2006, Nature Neuroscience.

[21]  S. Rivest,et al.  Unraveling the Molecular Details Involved in the Intimate Link between the Immune and Neuroendocrine Systems , 2004, Experimental biology and medicine.

[22]  G. Rosenberg,et al.  Matrix metalloproteinases and free radicals in cerebral ischemia. , 2005, Free radical biology & medicine.

[23]  G. Kollias,et al.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Tsutomu Takahashi,et al.  Tumor Necrosis Factor-α Neutralization Reduced Cerebral Edema Through Inhibition of Matrix Metalloproteinase Production After Transient Focal Cerebral Ischemia , 2005 .

[25]  S. Levison,et al.  Neuroinflammation and Both Cytotoxic and Vasogenic Edema Are Reduced in Interleukin-1 Type 1 Receptor-Deficient Mice Conferring Neuroprotection , 2005, Stroke.

[26]  P. Roux‐Lombard The interleukin-1 family. , 1999, European cytokine network.

[27]  M. Herkenham,et al.  Induction of inhibitory factor kappaBalpha mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Rivest,et al.  Is survival possible without arachidonate metabolites in the brain during systemic infection? , 2003, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[29]  W. Zhang,et al.  Protein-protein interactions involving inducible nitric oxide synthase. , 2003, Acta physiologica Scandinavica.

[30]  D Giulian,et al.  The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  P. Scheurich,et al.  Tumor necrosis factor signaling , 2003, Cell Death and Differentiation.

[32]  G. Higgins,et al.  Induction of interleukin-1β mRNA in adult rat brain , 1991 .

[33]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Waugh,et al.  Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. , 1991, Journal of immunology.

[35]  N. Rothwell,et al.  Functions and mechanisms of interleukin 1 in the brain. , 1991, Trends in pharmacological sciences.

[36]  C. Robertson,et al.  Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord , 1990, Annals of neurology.

[37]  S. Rivest,et al.  Role of Microglial-Derived Tumor Necrosis Factor in Mediating CD14 Transcription and Nuclear Factor κ B Activity in the Brain during Endotoxemia , 2000, The Journal of Neuroscience.

[38]  T. Bártfai,et al.  Cytokine Regulation of Neuronal Survival , 1992, Journal of neurochemistry.

[39]  J. Julien,et al.  Innate immunity: the missing link in neuroprotection and neurodegeneration? , 2002, Nature Reviews Neuroscience.

[40]  S. Mohand-Said,et al.  Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2 , 2002, The Journal of Neuroscience.

[41]  Henrik Ahlenius,et al.  Tumor Necrosis Factor Receptor 1 Is a Negative Regulator of Progenitor Proliferation in Adult Hippocampal Neurogenesis , 2006, The Journal of Neuroscience.

[42]  S. Paul,et al.  Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  N. Ling,et al.  Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  N. Rothwell,et al.  Interleukin 1 in the brain: biology, pathology and therapeutic target , 2000, Trends in Neurosciences.

[45]  V. Yong,et al.  Interleukin‐1 is a key regulator of matrix metalloproteinase‐9 expression in human neurons in culture and following mouse brain trauma in vivo , 2000, Journal of neuroscience research.

[46]  A. C. Webb,et al.  The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction , 1993, Molecular and cellular biology.

[47]  M. Mattson,et al.  Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.

[48]  J. Relton,et al.  Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. , 1993, Cerebrovascular and brain metabolism reviews.

[49]  B. Scallon,et al.  Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteins , 1994, European journal of immunology.

[50]  S. Rivest,et al.  Effects of Systemic Immunogenic Insults and Circulating Proinflammatory Cytokines on the Transcription of the Inhibitory Factor κBα Within Specific Cellular Populations of the Rat Brain , 1999, Journal of neurochemistry.

[51]  S. Rivest,et al.  Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  B. Lane,et al.  Fcγ Receptor Mediated Phagocytosis by Human Neutrophil Cytoplasts , 1999, Inflammation.

[53]  J. Dayer,et al.  Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? , 1984, Journal of immunology.

[54]  Y. Yamasaki,et al.  Possible involvement of interleukin-1 in ischemic brain edema formation , 1992, Neuroscience Letters.